Financial Statement and Notes to the Financial Statements This statement should be read in conjunction with the notes to the financial statements. CONSOLIDATED STATEMENT OF FINANCIAL POSITION As at 30 June 2014 Note 2014 2013 $ $ CURRENT ASSETS  Cash and cash equivalents  8  31,359,199  1,587,299 Trade and other receivables  9  121,587  105,073 Other current assets  10  2,966,739  30,218 TOTAL CURRENT ASSETS  34,447,525  1,722,590 NON-CURRENT ASSETS Property, plant and equipment  12  47,677  28,120 TOTAL NON-CURRENT ASSETS  47,677  28,120 TOTAL ASSETS  34,495,202  1,750,710 CURRENT LIABILITIES Trade and other payables  13  788,169  1,011,733 Provisions 15 166,511 98,637 TOTAL CURRENT LIABILITIES  954,680  1,110,370 TOTAL LIABILITIES  954,680  1,110,370 NET ASSETS  33,540,522  640,340 EQUITY Contributed equity  16  129,185,676  89,609,248 Reserves 17 640,773 277,910 Accumulated losses  (96,285,927)  (89,246,818) TOTAL EQUITY  33,540,522  640,340 Page 20 Benitec Biopharma Ltd  Annual Report 2014